Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products.
IIL operates one of the largest plants in the world for veterinary vaccines. IIL has adequate infrastructure and cold chain distribution capability to reach out to various parts of India and world market. This flexibility in logistics has ensured many products of IIL occupy top slots in the market.
IIL is a major player in the human vaccine market in India, focusing on the pediatric and rabies vaccine segments. IIL is also a major supplier of pediatric vaccines to India’s large Universal Immunization Programme.
Brief History of IIL
IIL started manufacturing human vaccines in 1998 on a specific request by the Government of India. IIL is the second company in the world and first in India to launch purified vero cell rabies vaccine (PVRV) and markets it under the brand – Abhayrab. This led to the discontinuation of use of older and unsafe sheep brain derived vaccine (also termed Nerve Tissue Vaccine – NTV) in the country.
IIL not only provides products and services to enhance the quality of livestock in the country, but also utilizes its technological capabilities for the benefit of the people.
Several billion doses
1st Indian tissue culture
World’s 1st vaccine for
Values and beliefs
We believe in providing affordable products with high quality through continuous technical innovations and improvements to meet our customer’s need.
We believe that a technology driven, value based, competitive organization can alone succeed in the global market.
We believe in inclusiveness, diversity, team work and continuous learning in our organization.
We value passion, competence and excellence in our people.
We value honesty, integrity and transparency in all our dealings.